These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 32622721)
1. Overexpression of lncRNA TINCR is associated with high-grade, invasive, and recurring tumors, and facilitates proliferation in vitro and in vivo of urothelial carcinoma of the bladder. Han Y; Sun G Urol Oncol; 2020 Sep; 38(9):738.e1-738.e8. PubMed ID: 32622721 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway. Xue M; Pang H; Li X; Li H; Pan J; Chen W Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536 [TBL] [Abstract][Full Text] [Related]
3. LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder. Pei L; Yan D; He Q; Kong J; Yang M; Ruan H; Lin Q; Huang L; Huang J; Lin T; Qin H Cell Oncol (Dordr); 2023 Oct; 46(5):1509-1527. PubMed ID: 37355516 [TBL] [Abstract][Full Text] [Related]
4. Hsa-miR-1 downregulates long non-coding RNA urothelial cancer associated 1 in bladder cancer. Wang T; Yuan J; Feng N; Li Y; Lin Z; Jiang Z; Gui Y Tumour Biol; 2014 Oct; 35(10):10075-84. PubMed ID: 25015192 [TBL] [Abstract][Full Text] [Related]
5. lncRNA Up-Regulated in Nonmuscle Invasive Bladder Cancer Facilitates Tumor Growth and Acts as a Negative Prognostic Factor of Recurrence. Zhang S; Zhong G; He W; Yu H; Huang J; Lin T J Urol; 2016 Oct; 196(4):1270-8. PubMed ID: 27267320 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of lncRNA snoRNA host gene 6 regulates NUAK family SnF1-like kinase-1 expression by competitively binding microRNA-125b and interacting with Snail1/2 in bladder cancer. Wang C; Tao W; Ni S; Chen Q J Cell Biochem; 2019 Jan; 120(1):357-367. PubMed ID: 30168179 [TBL] [Abstract][Full Text] [Related]
7. lncRNA TINCR SNPs and Expression Levels Are Associated with Bladder Cancer Susceptibility. Xu C; Liu M; Jia D; Tao T; Hao D Genet Test Mol Biomarkers; 2021 Jan; 25(1):31-41. PubMed ID: 33372851 [No Abstract] [Full Text] [Related]
8. Downregulation of miR-133b predict progression and poor prognosis in patients with urothelial carcinoma of bladder. Chen X; Wu B; Xu Z; Li S; Tan S; Liu X; Wang K Cancer Med; 2016 Aug; 5(8):1856-62. PubMed ID: 27292588 [TBL] [Abstract][Full Text] [Related]
9. lncRNA TINCR facilities bladder cancer progression via regulating miR‑7 and mTOR. Xu G; Yang H; Liu M; Niu J; Chen W; Tan X; Sun L Mol Med Rep; 2020 Nov; 22(5):4243-4253. PubMed ID: 33000269 [TBL] [Abstract][Full Text] [Related]
10. Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer. Dong H; Hu J; Zou K; Ye M; Chen Y; Wu C; Chen X; Han M Mol Cancer; 2019 Jan; 18(1):3. PubMed ID: 30621694 [TBL] [Abstract][Full Text] [Related]
11. lncRNA TINCR attenuates the proliferation and invasion, and enhances the apoptosis of cutaneous malignant melanoma cells by regulating the miR‑424‑5p/LATS1 axis. Han X; Jia Y; Chen X; Sun C; Sun J Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34542165 [TBL] [Abstract][Full Text] [Related]
12. Decreased lncRNA, TINCR, promotes growth of colorectal carcinoma through upregulating microRNA-31. Ren Z; Liu J; Li J; Yao L Aging (Albany NY); 2020 Jul; 12(14):14219-14231. PubMed ID: 32681722 [TBL] [Abstract][Full Text] [Related]
13. Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer. Zhan Y; Lin J; Liu Y; Chen M; Chen X; Zhuang C; Liu L; Xu W; Chen Z; He A; Zhang Q; Sun X; Zhao G; Huang W J Exp Clin Cancer Res; 2016 May; 35(1):83. PubMed ID: 27206339 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Huang L; Luo J; Cai Q; Pan Q; Zeng H; Guo Z; Dong W; Huang J; Lin T Int J Cancer; 2011 Apr; 128(8):1758-69. PubMed ID: 20549700 [TBL] [Abstract][Full Text] [Related]
15. Long Non-Coding RNA Cancer Susceptibility Candidate 2a (CASC2a) Is a Marker of Early Recurrence After Radical Cystectomy in Patients with Urothelial Carcinoma of the Bladder. Li Z; Wang KE; Zhou XL; Zhou J; Ye CH Med Sci Monit; 2018 Jan; 24():438-447. PubMed ID: 29358570 [TBL] [Abstract][Full Text] [Related]
16. miR‑589‑3p sponged by the lncRNA TINCR inhibits the proliferation, migration and invasion and promotes the apoptosis of breast cancer cells by suppressing the Akt pathway via IGF1R. Guo F; Zhu X; Zhao Q; Huang Q Int J Mol Med; 2020 Sep; 46(3):989-1002. PubMed ID: 32705168 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of terminal differentiation induced ncRNA (TINCR) suppresses proliferation and invasion in hepatocellular carcinoma by targeting the miR-218-5p/DEAD-box helicase 5 (DDX5) axis. Zhao H; Xie Z; Tang G; Wei S; Chen G J Cell Physiol; 2020 Oct; 235(10):6990-7002. PubMed ID: 31994189 [TBL] [Abstract][Full Text] [Related]
18. LncRNA PVT1 regulates growth, migration, and invasion of bladder cancer by miR-31/ CDK1. Tian Z; Cao S; Li C; Xu M; Wei H; Yang H; Sun Q; Ren Q; Zhang L J Cell Physiol; 2019 Apr; 234(4):4799-4811. PubMed ID: 30317572 [TBL] [Abstract][Full Text] [Related]
19. TINCR inhibits the proliferation and invasion of laryngeal squamous cell carcinoma by regulating miR-210/BTG2. He G; Pang R; Han J; Jia J; Ding Z; Bi W; Yu J; Chen L; Zhang J; Sun Y BMC Cancer; 2021 Jun; 21(1):753. PubMed ID: 34187411 [TBL] [Abstract][Full Text] [Related]
20. Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1. Han Y; Liu Y; Zhang H; Wang T; Diao R; Jiang Z; Gui Y; Cai Z FEBS Lett; 2013 Nov; 587(23):3875-82. PubMed ID: 24396870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]